Skip to main content
ANTX logo

ANTX · AN2 Therapeutics, Inc. · Executive Compensation

Track ANTX — free
$5.61 -0.10 (-1.75%) At close · Oct 5
Market Cap
$192.45M
Shares
37.74M
Volume · Oct 5 299.95K Avg daily vol (3M) 234.2K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Eric Easom $1,382,985
Josh Eizen $807,080
Lucy Day $774,336
Fiscal 2024
Executive Total
Eric Easom $1,666,117
Josh Eizen $1,057,350
Paul Eckburg $946,501
Lucy Day $812,699
Fiscal 2023
Executive Total
Eric Easom $3,342,848
Lucy Day $1,524,458
Paul Eckburg $1,453,786
Josh Eizen $1,147,944
Fiscal 2022
Executive Total
Eric Easom $3,465,533
Paul Eckburg $1,393,156
Joshua Eizen $1,354,563
Lucy Day $1,328,603
Fiscal 2021
Executive Total
Eric Easom $1,718,989
Paul Eckburg $903,053

Executive changes

Person Change Filed
Sarah Williams Appointed 2026-01-29
Joshua Eizen Appointed 2024-11-05
Paul Eckburg, M.D. Terminated 2024-08-08
Lucy Day Appointed 2023-09-08
Key facts CIK 1880438 CUSIP 037326105 13F (30d) 6 filings 2 filers Visit website Investor relations